Histochemistry and Cell Biology

, Volume 148, Issue 5, pp 489–501 | Cite as

Involvement of Atm and Trp53 in neural cell loss due to Terf2 inactivation during mouse brain development

Open Access
Original Paper


Maintenance of genomic integrity is one of the critical features for proper neurodevelopment and inhibition of neurological diseases. The signals from both ATM and ATR to TP53 are well-known mechanisms to remove neural cells with DNA damage during neurogenesis. Here we examined the involvement of Atm and Atr in genomic instability due to Terf2 inactivation during mouse brain development. Selective inactivation of Terf2 in neural progenitors induced apoptosis, resulting in a complete loss of the brain structure. This neural loss was rescued partially in both Atm and Trp53 deficiency, but not in an Atr-deficient background in the mouse. Atm inactivation resulted in incomplete brain structures, whereas p53 deficiency led to the formation of multinucleated giant neural cells and the disruption of the brain structure. These giant neural cells disappeared in Lig4 deficiency. These data demonstrate ATM and TP53 are important for the maintenance of telomere homeostasis and the surveillance of telomere dysfunction during neurogenesis.


Atm DNA damage Apoptosis Brain development 



DNA double-strand breaks


DNA damage response


Postnatal day


Embryonic day


Ventricular zone


Corpus callosum


Genomic instability resulting from DNA damage induced by either endogenous or exogenous insults could lead to defective neurodevelopment and neurological diseases (Lee et al. 2016). Ataxia telangiectasia mutated (ATM) is one of the early responders to DNA damage, particularly to DNA double-strand breaks (DSBs). ATM mutations cause Ataxia Telangiectasia (A-T) characterized by ataxia due to loss of Purkinje and granule cells in the cerebellum (McKinnon 2012, 2013). Similarly, Ataxia-telangiectasia and RAD3-related (ATR) recognizes single-stranded DNA resulting from replication stress. Seckel syndrome 1 (SCKL1) due to hypomorphic mutations in the ATR gene is characterized by microcephaly and mental retardation (Nam and Cortez 2011; McKinnon 2013). Once activated by DNA damage, ATM and ATR phosphorylate several overlapping substrates including tumor protein p53 (TP53/Trp53 in mice) to regulate DNA damage repair, apoptosis, and cell cycle arrest (Lee et al. 2001, 2012b; Lovejoy and Cortez 2009). Although it is well known that ATM and ATR are required to maintain genomic integrity, the precise roles of ATM and ATR during brain development are not fully understood, especially related to neuropathology such as ataxia, neurodegeneration, and microcephaly observed in human patients.

Telomere dysfunction is one of the endogenous sources to induce DNA damage response (DDR), since the unprotected telomere ends could be recognized as DNA strand breaks (de Lange 2005). To protect this DNA region, the telomere ends are coated with the Shelterin complex, which is composed of several proteins including telomeric repeat binding factor 2 (TERF2) and protection of telomeres 1 (POT1), to prevent telomere attrition and inappropriate DDR induction (de Lange 2005; Palm and de Lange 2008). TERF2 homodimers bind to double-stranded regions of telomeres and inactivation of TERF2 triggers ATM-dependent DDR signals, whereas POT1 protects the 3′ single-stranded overhang and its inactivation initiates ATR-dependent DDR signals at the cellular level (Karlseder et al. 1999; Zhang et al. 2006, 2007; Denchi and de Lange 2007; Sfeir and de Lange 2012). The exposed telomere ends as a result of Terf2 inactivation were processed by DNA ligase IV (Lig4) which is the ligase for the canonical Non-homologous end-joining repair (NHEJ) pathway for DSBs (Celli and de Lange 2005; Lee et al. 2016; Smogorzewska et al. 2002). The involvement of ATM and ATR in DDR induced by telomere dysfunction was mutually exclusive in this context.

However, selective deletion of the Pot1a gene during mouse brain development resulted in Atm-dependent neurological phenotypes including cerebellar defects, suggesting that telomere dysfunction might induce DDR in a tissue-specific manner during neurogenesis (Lee et al. 2014). For the current study, we asked whether telomere dysfunction due to Terf2 inactivation also induces neuro-specific DDR associated with Atm or Atr signaling pathway during neurogenesis.

Materials and methods


Floxed Terf2 animals (Karlseder et al. 1999; Celli and de Lange 2005) were purchased from the Jackson Laboratory (JAX #006568). Germline deletion of the Terf2 gene caused embryonic lethality at mid-gestation in the mouse (Celli and de Lange 2005). In order to restrict inactivation of the Terf2 gene in the nervous system during development, Terf2 LoxP/+ animals were interbred with Nestin-Cre animals (JAX #003771) or Emx1-Cre animals (JAX #005628). Cre recombinase expression driven by the Nestin promoter is active around embryonic day (E) 11 throughout the neural progenitors, whereas the Emx1 promoter is activated only in the dorsal telencephalon and the hippocampal progenitors around E10 during mouse embryogenesis (Gorski et al. 2002; Graus-Porta et al. 2001; Tronche et al. 1999). Terf2 LoxP/LoxP ;Nestin-Cre and Terf2 LoxP/LoxP ;Emx1-Cre mice were obtained through a proper breeding scheme. Conditional knockout animals could not be used for breeding. Terf2 LoxP/+ ;Nestin-Cre or Emx1-Cre animals did not show any discernable defects or shortened life span, and they were fertile. So these animals were included in control groups. Mutant alleles of Atm, Atr LoxP , Trp53 LoxP , Lig4 LoxP , and Pot1a LoxP genes and the polymerase chain reaction (PCR) conditions for genotyping were as previously described (Lee et al. 2001, 2012b, 2014; Shull et al. 2009). All animals were maintained in a mixed strain of C57BL/6 X 129 genetic background. Since we could not find any gender difference of DDR in the brain before (Lee et al. 2001, 2012a, 2014), we analyzed the experimental materials regardless of gender for the current study. Also Nestin-Cre expression was maintained in females for breeding to minimize any ectopic Cre recombinase activity outside of the nervous system. Genotypes of genetically engineered animals were determined by a routine PCR method using the following primers: Terf2 (Forward: 5′ ccaaccagggatacacagtga, Reverse: 5′ atccgtagttcctcttgtgtctg), Pot1a (Forward: 5′ ctcgaattccatctcctcccagtactctctcag, Reverse: 5 ggaactggtacgtatcagtgtgtgtgg), Atm wildtype ( WT) allele (Forward: 5′ gcctgtatcttctatgtgcaccgtcttcgc, Reverse: 5′ ggtgcggtgtggatgggactggagg), Atm targeted allele (Forward: 5′ gtgatgacctgagacaagatgctgtc, Reverse: 5′ gggaagacaatagcaggcatgc), Atr (Forward: 5 tacattttagtcatagttgcataacac, Reverse: 5 cttctaatcttcctccagaattgtaaaagg), Lig4 (Forward: 5′ atcgctcttgtcccagtacacctgc, Reverse: 5 gtgcattaaatggagtgctgtgc), Trp53 (Forward: 5′ cacaaaaacaggttaaacccag, Reverse: 5′ agcacataggaggcagagac).

PCR products for Terf2 genotyping were amplified for 35 cycles of 94 °C for 30 s, 60 °C for 45 s, and 72 °C for 45 s. PCR products for WT and floxed alleles (LoxP) of the Terf2 gene were 233 and 300 bp, respectively.

All of animal materials for experiments were courteously provided by Dr. Peter McKinnon (St. Jude Children’s Research Hospital, USA). The presence of a vaginal plug was indicated as E.5 and the day of birth as postnatal day (P) 0. All animals were housed in an AAALAC accredited facility and were maintained in accordance with the National Institutes of Health ‘Guide for the Care and Use of Laboratory Animals’. All procedures for animal use were approved by the Institutional Animal Care and Use Committee.


Histopathological procedures were performed as previously described (Lee et al. 2012a, 2014). In brief, both embryos and brains were collected at indicated time points after the fixation step using 4% phosphate-buffered paraformaldehyde. Cryosections of embryos or brains at 10 μm were collected using an HM500M (Microm) or an MEV (SLEE medical GmbH) cryostat for pathological analysis. Hematoxylin and Eosin (H/E), and Nissl staining were carried out in a routine procedure. Immunoreactivity was visualized by either colorimetric detection using the VIP substrate kit (Vector Labs) reactive with biotinylated secondary antibodies or fluorometric detection using FITC/CY3 conjugated secondary antibodies (Jackson Immunologicals) after incubation with primary antibodies. Counterstaining was done with 0.1% methyl green in 0.1 M sodium acetate buffer for colorimetric staining followed by mounting with DPX (Sigma) or DAPI/PI counterstaining mounting medium (Vector Laboratories) for fluorometric staining.

Antibodies used for this study were Calbindin (mouse, 1:2000, Sigma-Aldrich), Ctip2 (rat, 1:100, Abcam), Cux1 (rabbit, 1:100, Santa Cruz), Foxp2 (rabbit, 1:500, Abcam), GFAP (mouse, 1:500, Sigma-Aldrich), γ-H2AX (rabbit, 1:100, Cell signaling), γ-tubulin (mouse, 1:1000, Sigma-Aldrich), Histone H3phosphoS10 (rabbit, 1:2000, Cell signaling), MBP (myelin basic protein, rabbit, 1:200, Abcam), Myelin-PLP (rabbit, 1:200, Abcam), NeuN (mouse, 1:500, Millipore), Neuronal Class III β tubulin (clone TUJ1, mouse, 1:1000, Covance Research), Tbr1 (rabbit, 1:500, Abcam). Depending on primary antibodies, the citric acid-based antigen retrieval method was applied to enhance immunoreactive signals.

TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay using Apoptag (Chemicon) was applied to measure apoptosis. Multiple histological slides were examined and imaged using an Axio Imager A1 microscope (Zeiss) or B600TiFL (Optika). Microscopic images were captured and processed using Photoshop (v.CS6.5, Adobe).

Telomere in situ using telomere-PNA probe

To detect telomere in situ, tissue sections were dehydrated in alcohol series, denatured at 80 °C for 4 min, followed by incubation for 4 h in the dark at room temperature with CY3-CCCTAACCCTAACCCTAA peptide nucleic acid (PNA) telomere probe (0.7 μg/ml, Panagene) in 70% formamide, 10 mM Tris–HCl pH 7.5, 5% MgCl2 buffer (82 mM Na2HPO4, 9 mM citric acid, 25 mM MgCl2), and 1% blocking reagent (Roche). Then, sections were washed with Solution I (70% formamide, 10 mM Tris–HCl pH 7.2, 0.1% BSA) and Solution II (0.05 M Tris–HCl pH 7.2, 0.15 M NaCl, 0.05% Tween 20) several times. After washing, slides were mounted with DAPI-containing aqueous mounting medium (Vector). Images were captured and analyzed as described in the “Histology” method section.


Terf2 was essential for brain development

It has been reported that germline deletion of the Terf2 gene caused embryonic lethality at mid-gestation in the mouse (Celli and de Lange 2005). So, we restricted Terf2 inactivation to the nervous system by cross-breeding of the Terf2 floxed animal model with either Nestin-Cre (Terf2 LoxP/LoxP ;Nestin-Cre, hereafter Terf2 Nes-Cre ) or Emx1-Cre (Terf2 LoxP/LoxP ;Emx1-Cre, hereafter Terf2 Emx1-Cre ) animal lines during development.

Although the Terf2 gene was targeted only in the nervous system during mouse development, all of Terf2 Nes-Cre mice were born dead without a proper brain structure (data not shown). The overall body size of Terf2 Nes-Cre animals was comparable to that of controls at birth (data not shown). On the other hand, Terf2 Emx1-Cre animals were born at normal Mendelian ratio. These mutant animals became runted and succumbed around 1 month after birth. The Terf2 Emx1-Cre brains showed complete loss of the brain region in which Emx1-Cre is expressed (Fig. 1a, b). Terf2 LoxP/+ ;Nestin-Cre or Emx1-Cre animals did not show any discernable neurological defects, so these genotypes of animals alone with WT animals were considered as control groups.
Fig. 1

Terf2 inactivation during neurogenesis resulted in obliteration of the brain structure. a The view from the top of Terf2 conditional knockout brains at 3 weeks of age. The skull was partially removed to show the brain structure. The eyeballs were intact. The control brain was fully developed, yet the Terf2 Emx1-Cre brain had the cerebral cortical part missing in which the Emx1 promoter-driven Cre recombinase was expressed, so the colliculus (col) was fully exposed. Red arrows indicate the part lost in the Terf2 Emx1-Cre brain. These missing brain parts were partially restored in both Atm and Trp53-null backgrounds. ce cerebellum, col colliculus, ctx cerebral cortex, ob olfactory bulb. Ctrl control, the ruler in mm. b Nissl staining of the mature brains. The sagittal (upper panel) and parasagittal (lower panel) views of 3-week-old brains in different genetic backgrounds. Upper panel the brain areas expressing Cre recombinase controlled by the Emx1 promotor were completely missing (Terf2 Emx1-Cre ), but the partial recovery of the brain areas was observed in Atm-, Trp53- and Lig4/Trp53-null backgrounds (Terf2 Emx1-Cre ;Atm /, (Terf2;Trp53) Emx1-Cre and (Terf2;Lig4;Trp53) Emx1-Cre ). Also Trp53 deficiency rescued embryonic lethality as well as partially the missing brain structure in Terf2 Nes-Cre animals. Lower panel the hippocampus, one of the important brain structures for memory, in the conditional knockout brains was not formed. Either Atm or Trp53 deficiency was not sufficient enough to restore the hippocampal structure. However, the (Terf2;Lig4;Trp53) Emx1-Cre brain displayed a partial recovery of the hippocampus. In the parasagittal section, the matched brain part containing the hippocampus in the Emx-1 Cre background was completely gone, since the Emx1-Cre was expressed in this particular brain structure during neurogenesis. The dotted red lines demarcate some brain areas affected by Terf2 inactivation, such as the cerebral cortex and hippocampus. CC corpus callosum, ce cerebellum, Cpu caudate putamen, ctx cerebral cortex, th thalamus, hipp hippocampus (CA1/2/3 Cornu Ammonis areas 1/2/3, DG dentate gyrus), tm tectum. The scale bar is 1.2 mm

Terf2 inactivation induced massive neural apoptosis during development

Loss of the brain regions in which Cre recombinase was expressed at birth led us to examine the embryonic brains during neurogenesis. The Terf2 Nes-Cre embryos at E13.5 showed massive apoptosis measured by TUNEL throughout the developing brain (Fig. 2a). As a result, there was no proper brain structure found by E15.5 in a Nestin-Cre background (Fig. 2b). Similarly, Terf2 Emx1-Cre embryos had only the vestige of the forebrain with residual apoptosis at E13.5 (Fig. 2c), and a complete disappearance of the Emx1-Cre expressing areas by E15.5 (Fig. 2d), while the ganglionic eminence in which Emx1-Cre is not expressed was intact during neurogenesis. These data suggest an essential requirement of TERF2 and the importance of telomere stability for cell survival during neurogenesis.
Fig. 2

Massive apoptosis occurred in the Terf2-deficient developing brain. a TUNEL analysis to detect neural apoptosis. The embryonic forebrain (cortex) and colliculus area at embryonic day (E) 13.5 with TUNEL staining. The controls (Terf2 ctrl , Atr Nes-Cre , Atm / and Trp53 Nes-Cre ) showed only the basal levels of TUNEL positivity (green staining), and there was no difference among the control groups. However, massive apoptosis was observed in the Terf2 Nes-Cre and (Terf2;Atr) Nes-Cre developing brains, while a dramatic reduction of programmed cell death was evident in both Terf2 Nes-Cre ;Atm / and (Terf2;Trp53) Nes-Cre embryonic cortex and colliculus. Green fluorescent apoptotic debris were falling off inside of the ventricle (V) in the Terf2 Nes-Cre and (Terf2;Atr) Nes-Cre embryonic brains. Ctrl control. b Tuj1 (Neuron-specific class III beta-tubulin, marker for postmitotic neurons) positive immuno-staining. Left panel the heads of embryos (at E15.5) with Tuj1 immunoreactivity (purple color) at low magnification show that the Terf2 Nes-Cre and (Terf2;Atr) Nes-Cre brains were completely gone by E15.5 (red arrowheads), yet the brain structure was partially rescued in both Atm and Trp53 deficiency (red arrows). The ventricular zone was not positive for Tuj1 immunoreactivity, so methyl green staining (counterstaining) was visible in this zone. Right panel high magnified views of the forebrains (cortex) in experimental groups. The Terf2 Nes-Cre and (Terf2;Atr) Nes-Cre embryos did not have any brain structure which was positive for Tuj1 immuostaining (purple color). Two pictures of Terf2 Nes-Cre and (Terf2;Atr) Nes-Cre heads show only a part of the skull and scalp. The missing brain parts were restored in both Atm and Trp53 null backgrounds (Terf2 Nes-Cre ;Atm / and (Terf2;Trp53) Nes-Cre ). Methyl green was used for counterstaining so that the ventricular zone could be identifiable. V ventricle. c H/E and TUNEL staining of the Emx1-Cre expressing brains at E13.5. Left panel Hematoxylin/Eosin (H/E) staining of the embryonic brains shows that the Cre expressing area (red line) was gone in Terf2 Emx1-Cre and (Terf2;Atr) Emx1-Cre embryos, but the affected brain area was partially restored in both Atm / and Trp53 Emx1-Cre backgrounds. The control animals including Terf2 ctrl , Atr Emx1-Cre , Atm / and Trp53 Emx1-Cre brains did not show any morphological defects. The ganglionic eminence (GE) was intact in the (Terf2) Emx1-Cre embryonic brains, since Emx1-Cre is not expressed in the GE. The red lines demarcate the Emx1-Cre expressing area. GE ganglionic eminence, V ventricle. Right panel apoptosis detected by TUNEL (green color) shows increased apoptosis in the Emx1-Cre expressing area of the Terf2 conditional knockout brains (Terf2 Emx1-Cre and (Terf2;Atr) Emx1-Cre ), but not in the GE. Atm and Trp53 deficiency (but not Atr deficiency) attenuated apoptosis resulting from Terf2 inactivation in the developing brain. d Apoptosis measured by TUNEL at E15.5. Terf2-inactivated brain parts were gone completely in the Terf2 Emx1-Cre and (Terf2;Atr) Emx1-Cre embryos by E15.5 (No CTX formed). Even though the missing part in the developing brain was partially restored, the Terf2 Emx1-Cre ;Atm / forebrain (cortex: CTX) showed apoptosis restricted to the ventricular zone (VZ), and there was no significant sign of programmed cell death observed in the (Terf2;Trp53) Emx1-Cre and (Terf2;Lig4;Trp53) Emx1-Cre developing brains. However, the restored brain area in a Trp53-null background contained irregular cellularity (white asterisk), which was not observed in the Terf2 Emx1-Cre ;Atm / and (Terf2;Lig4;Trp53) Emx1-Cre embryonic brains. Since Atr or Lig4 inactivation during brain development also induces neuronal cell death, the level of programmed cell death found in the Atr Emx1-Cre and Lig4 Emx1-Cre embryonic brains was as expected. GE ganglionic eminence, VZ ventricular zone. The scale bars in b and c left panels are 1.2 mm, and the scale bars in the rest of the photomicrographs are 200 μm

Atm and Trp53, but not Atr, inactivation rescued neural apoptosis resulting from Terf2 deficiency

Previously, it has been demonstrated that DNA damage triggered by Terf2 inactivation in vitro induced Atm-dependent Atr-independent DDR (Karlseder et al. 1999; Celli and de Lange 2005; Zhang et al. 2006, 2007; Denchi and de Lange 2007). So, next we tested the in vivo involvement of Atm and Atr, as well as Trp53, a common downstream substrate, in lethality and massive neural apoptosis resulting from Terf2 inactivation during neurogenesis. Floxed Terf2 animals were cross-bred with Atr (conditional inactivation: Atr Nes-Cre and Atr Emx1-Cre ), Atm (germline inactivation: Atm /) or Trp53 (conditional inactivation; Trp53 Nes-Cre and Trp53 Emx1-Cre ) animals. Similar to the in vitro situation (Denchi and de Lange 2007; Karlseder et al. 1999), Atr inactivation did not have any influence on the phenotypes observed in both Terf2 Nes-Cre and Terf2 Emx1-Cre animals (Fig. 2). Terf2 Emx1-Cre ;Atm / and (Terf2;Trp53) Emx1-Cre animals also did not show any discernible improvement in gross phenotypes including smaller body size and shorter life span observed in the Terf2 Emx1-Cre animals (data not shown).

In a Nestin-Cre background, Atm inactivation could not rescue prenatal lethality resulting from Terf2 inactivation, while (Terf2;Trp53) Nes-Cre animals were born alive. Noticeably, (Terf2;Trp53) Nes-Cre animals displayed severe ataxia, hence could live only up to the time of weaning (supplementary video clip). This severe ataxic phenotype resulted from the malformation of the cerebellum which was very small and did not have any organized structure of the cerebellum, particularly a complete disruption of the Purkinje cell layer (Fig. 3a). Yet the mutant cerebellum contained all of the cellular components including Purkinje cells (Calbindin immuno-positive), Bergmann glia (glial fibrillary acidic protein (GFAP) immuno-positive), and oligodendrocytes (myelin basic protein (MBP) and myelin proteolipid protein (Myelin-PLP) immuno-positive), except granule cells (NeuN immuno-positive) (Fig. 3a). Tumorigenicity in the nervous system of the (Terf2;Trp53) Nes-Cre animals could not be evaluated because of a short life span.
Fig. 3

Terf2 inactivation disrupted the brain structure. a Developmental defects in the (Terf2;Trp53) Nes-Cre cerebellum. Nissl staining indicates that the (Terf2;Trp53) Nes-Cre cerebellum was much smaller (red arrowhead) and the size of cells inside was bigger and not organized. The Purkinje cell layer (yellow arrowhead) detected by Calbindin immunostaining displayed the complete misalignment of the layer and could not be found as a single cell layer as shown in the control brain. Glial fibrillary acidic protein (GFAP) immunoreactivity shows the disruption of the Bergmann glial network (yellow arrow). The populations of neurons (NeuN immuno-positive) and oligodendrocytes (MBP and Myelin-PLP immuno-positive) were strikingly reduced, and the structure was disorganized (red arrows). These cerebellar defects lead to severe ataxia in the (Terf2;Trp53) Nes-Cre animals (see the accompanied video clip). Mo the molecular layer in the cerebellum, Gr the granule cell layer in the cerebellum, Ctrl control. Scale bars are as indicated in the figures. b Disruption of the six-layered cortical structure. The layered cortical structure in the 3-week-old brain was examined with four different markers; the upper layers—Cux1; the lower layers—Tbr1, Ctip2, Foxp2. The rescued part of the Terf2-null cortex in either Atm or Trp53 deficiency ((Terf2;Trp53) Nes-Cre , Terf2 Emx1-Cre ;Atm / and (Terf2;Trp53) Emx1-Cre ) did not form the upper layers (Cux1 immuno-positive), and the layers IV, V, VI were located to the upper part of the cortex. In contrast, the (Terf2;Lig4;Trp53) Emx1-Cre cortex displayed all six layers including the upper layers (Cux1 immuno-positive). The size of immunopositive cells to the layer markers in the Terf2/Trp53 dual null cortex was much bigger and less organized than that of controls. Roman numeric signs indicate the cortical layers. The white dotted lines indicate the surface of the cerebral cortex. The scale bar is 100 μm

Although both Atm and Trp53 inactivation could reduce apoptosis dramatically in the Terf2-null brains (Fig. 2), there was a difference between these two genetic backgrounds. Neural cell death in both Terf2 Nes-Cre and Terf2 Emx1-Cre embryos had disappeared by E15.5 in a Trp53-null background, whereas Atm inactivation could not stall most of the apoptosis in the ventricular zone (VZ) where neural progenitor cells are located in (Fig. 2d).

The multiple defects were found in the Terf2-null brains

Although neuron-specific class III β-tubulin (Tuj1), which is a marker for postmitotic neurons, showed a normal distribution in the developing brains of the Terf2/Atm and Terf2/p53 double null embryos (Fig. 2b), the restored portion in the mature brains exhibited several faulty features. Trp53 inactivation led to better restoration of the missing parts in the Terf2-null brain than Atm deficiency did. However, the restoration was still incomplete (Fig. 1b). The hippocampus was not restored in the Terf2/Atm and Terf2/Trp53 double null brains (Fig. 1b).

Next, we analyzed the six-layered cerebral cortical structure created in an inside-out manner during development (Greig et al. 2013). The Foxp2, Ctip2, and Tbr1 immuno-positive neurons, which are generated during an early stage of cortical development and localized in the lower layers of the cerebral cortex in normal development, were found in the upper cortical part of the (Terf2;Trp53) Nes-Cre and (Terf2;Trp53) Emx1-Cre brains (Fig. 3b). Similarly, the Terf2 Emx1-Cre ;Atm / cortex showed mis-localization of Ctip2 and Tbr1 immuno-positive neurons. Furthermore, there were no proper upper layers formed (layers I, II, and III), which were Cux1 immuno-positive, in both the Terf2/Atm and Terf2/Trp53 double null cortices, suggesting that the Terf2-null developing brain could not generate cortical neurons at the later stage during development in both Atm- and Trp53-deficient backgrounds (Fig. 3b).

Increased GFAP immunoreactivity was one of common features found in the brains of genomic instability animal models (Shull et al. 2009; Lee et al. 2012a, b). So we tested whether Terf2-deficient brains also exhibit increased GFAP immunoreactivity as a sign of genomic instability. Indeed the Terf2-null cortex showed increased GFAP immunopositivity in both Atm- and p53-null backgrounds (Fig. 4a). Interestingly, the size of GFAP immuno-positive cells in Terf2/Trp53 double null brains was relatively big (Fig. 4a). On the contrary, the dramatic reduction of oligodendrocyte population which was visualized by MBP and Myelin-PLP immunoreactivity was found in the Terf2/Atm and Terf2/Trp53 double null cortices (Fig. 4b). However, all of the Terf2-null cortices were in the absence of the corpus callosum (CC) structure, which functions as a communication path between two cerebral hemispheres (Fig. 4a, b).
Fig. 4

Defective glia network was formed in the mutant brain. a Increased immunoreactivity of GFAP in the Terf2 mutant brain. The Terf2-null brains in both Atm- and Trp53-deficient backgrounds showed the high level of GFAP immuno-staining compared to that of the control brain, which is a common feature found in the brain of genomic instability animal models. The corpus callosum, which is a glia-rich structure, was not defined in the Terf2-null brain ((Terf2;Trp53) Nes-Cre , Terf2 Emx1-Cre ;Atm / and (Terf2;Trp53) Emx1-Cre ). The (Terf2;Lig4;Trp53) Emx1-Cre brain showed partial recovery of the corpus callosum. The red dotted lines demarcate the normal corpus callosum in the control brain and the partially restored corpus callosum in the (Terf2;Lig4;Trp53) Emx1-Cre brain. The size of GFAP immuno-positive cells in the Terf2/Trp53 double null brains, not in both Terf2/Atm double and Terf2/Lig4/Trp53 triple deficient brains, was bigger than that of controls (red arrows). The scale bar is 200 μm. b Defective oligodendrocyte network in the Terf2 mutant brain. Oligodendrocytes were detected by two different markers: MBP (myelin basic protein) and Myelin-PLP (proteolipid protein). The Terf2 ctrl cerebral cortex displayed a rich network of oligodendrocytes, particularly in the corpus callosum. However, the Terf2 conditional knockout brains in all different genetic backgrounds showed a dramatic reduction of immunopositivity to MBP/Myelin-PLP, and agenesis of the corpus callosum (red arrows), in contrast to the increased astrocyte population in the Terf2-null brains (A panel above). And the genetic combination with Atm or Trp53 deficiency could not improve this defect. However, Lig4 inactivation resulted in partial recovery of the corpus callosum in the (Terf2;Trp53) Emx1-Cre brain. The corpus callosum shown in the lower panel was the posterior part of the corpus callosum. The scale bars are 100 μm

Trp53 inactivation resulted in multinucleated giant neural cells in the Terf2-null brain

Furthermore, we noticed the existence of giant neural cells only in the Terf2/Trp53 double null brains, not in the Terf2/Atm double null brains (Figs. 3, 4a, 5a). Each giant cell contained irregular shaped multiple nuclei connected to each other by thin strings (Fig. 5a).
Fig. 5

The multinucleated giant neural cells were found only in the Terf2/Trp53 double null brain. a Giant neural cells in the Terf2/Trp53 double null brains and a sign of DNA damage in the Terf2 null brain. The neural cells including neurons in the brain, particularly the cerebral cortex (CTX), were examined by Nissl staining and NeuN immunoreactivity. Giant neural cells were found only in the (Terf2;Trp53) Nes-Cre and (Terf2;Trp53) Emx1-Cre cortices. Giant neural cells had multiple nuclei in a single cell visualized by DAPI staining in the Terf2/Trp53 double deficient cortex. This kind of giant neural cells were not observed in the Terf2 Emx1-Cre ;Atm / and (Terf2;Lig4;Trp53) Emx1-Cre cortices. DNA damage or breaks could be visualized by immunostaining of phosphorylated H2AX (γ-H2AX) as foci formation in the nucleus. γ-H2AX foci were abundant in the giant nuclei of the Terf2/Trp53 double null cortices. Since Lig4 deficiency itself results in accumulation of γ-H2AX foci, the (Terf2;Lig4;Trp53) Emx1-Cre cortex showed strong foci formation in the nucleus. Telomeres were visualized by hybridization with Telomere-PNA probe conjugated with CY3 (red). Only the Terf2-null cortices in all different genetic backgrounds showed the high level of PNA probe positivity indicating that the PNA-telomere probe was hybridized better with telomeres in the Terf2-null brains. The blue staining was DAPI staining for γ-H2AX immunostaining and PNA-telomere in situ detection. The scale bars are 100 μm except γ-H2AX immunostaining. b The high level of γ-H2AX foci and big chromosomes in the Terf2-null embryonic cortex during embryogenesis. DNA damage visualized by γ-H2AX foci was evident in the Terf2-null embryonic fore brains in different genetic backgrounds as well as in the Pot1a Nes-Cre embryonic brain, particularly in the ventricular zone (VZ) of the cortex. A big conglomeration of chromosomes detected by phosphorylated H3 (H3pS10) immunoreactivity (green staining) was observed only in the Terf2/Trp53 double null metaphase cells ((Terf2;Trp53) Nes-Cre and (Terf2;Trp53) Emx1-Cre ), not in Terf2/Atm double and Terf2/Lig4/Trp53 triple null metaphase cells. Centrosomes were visualized by γ-tubulin immunoreactivity (yellow arrowheads). Only Terf2/Trp53 double null metaphase cells in both Nestin and Emx-1 Cre backgrounds had multiple centrosomes (red staining) in a single-metaphase cell. Terf2 Nes-Cre ;Atm / , Terf2 Emx1-Cre ;Atm / and (Terf2;Lig4;Trp53) Emx1-Cre neural progenitor cells at metaphase had two centrosomes the same as the control embryonic brain (yellow arrowheads). Pot1a deficiency (Pot1a Nes-Cre ) did not show any similar defects such as a big aggregation of chromosomes and multiple centrosomes. The scale bars are as indicated in the figure. c A schematic illustration of signaling pathways induced by either DNA damage or telomere dysfunction to trigger apoptosis or cell cycle arrest during brain development. Telomere dysfunction resulting from either TERF2 or POT1a inactivation induces neural apoptosis which is ATM-Trp53 dependent during neurogenesis. Terf2 inactivation directly activates ATM-dependent signaling, while Pot1a inactivation induces ATM activation via ATR signaling during neurogenesis

Also, the considerable amounts of DNA damage visualized by phosphorylated H2AX (γ-H2AX) foci formation, which is a good marker for DNA strand breaks, were detected in all of the Terf2-null brains, but not in the control brain (Fig. 5a). In addition, telomere in situ visualization using a telomere-PNA probe showed its conjugated CY3 signals in the Terf2-null brains (Fig. 5a). These telomere-PNA signals were not noticeable in the control brain, suggesting that telomeres in Terf2-null neural cells were readily accessible by the telomere-PNA probe since they were not well protected.

Next we examined whether multinucleated giant neural cells were formed during neurogenesis. Certainly, γ-H2AX foci formation in the Terf2-null brains, particularly in the VZ of the developing brains, was dramatically increased in both Atm- and Trp53-deficient backgrounds (Fig. 5b). However, the chromosome mass at metaphase visualized by phosphorylated H3 immunoreactivity (H3pS10) showed a significant increase only in the Terf2/Trp53 double null neural progenitors (Fig. 5b). This giant chromosomal mass was not observed in an Atm-null background. It is possible that this giant chromosomal aggregation might partially result from incomplete cell division, since multiple centrosomes detected by γ-tubulin immunoreactivity in a single cell were observed only in the Terf2/Trp53 double null neural cells at metaphase (Fig. 5b). Even though DNA damage detected by γ-H2AX foci was evident, neural progenitor cells with giant chromosomal mass were not observed in the Pot1a Nes-Cre embryonic brains (Fig. 5b); consequently, there were no multinucleated giant neural cells found in the Pot1a Nes-Cre mature brains (Lee et al. 2014).

DNA ligase IV plays a role in neural abnormalities due to Terf2 deficiency during neurogenesis

Previously it was reported that Lig4 plays a role in abnormal fusions of telomere ends in Terf2-deficient cells (Celli and de Lange 2005; Smogorzewska et al. 2002). So we tested whether Lig4 inactivation during neurogenesis could alleviate neural abnormalities observed in the (Terf2/Trp53) Emx1-Cre brain. As described before (Lee et al. 2012a), the (Lig4;Trp53) Emx1-Cre brain did not show any neural phenotypes related to telomere dysfunction. The triple conditional knockout animals (hereafter (Terf2;Lig4;Trp53) Emx1-Cre ) were born alive, but the (Terf2;Lig4;Trp53) Emx1-Cre animals died around 1 month of age similar to the (Terf2;Trp53) Emx1-Cre animals.

Neuropathological analysis revealed that the neurological abnormalities were moderately corrected in the (Terf2;Lig4;Trp53) Emx1-Cre brain. During embryogenesis, the reduction of neural cell death in the (Terf2;Lig4;Trp53) Emx1-Cre embryos was the same as the (Terf2;Trp53) Emx1-Cre embryos, most likely due to the effect of Trp53 inactivation (Fig. 2d). However, proliferating cells at metaphase in the (Terf2;Lig4;Trp53) Emx1-Cre VZ were similar to those with two centrosomes found in control embryos (Fig. 5b). Consequently, the most obvious correction was disappearance of multinucleated giant cells in the triple conditional null mature brain (Figs. 4a, 5a). In addition, the upper layers of the cerebral cortex, which are Cux1 immuno-positive, were formed in the triple null brain (Fig. 3b). However, this recovery by Lig4 inactivation was not complete, such as partial reconstruction of the hippocampus and CC compared to the control groups (Figs. 1b, 4).


Telomere homeostasis is essential for brain development in the mouse

The role of TERF2 and POT1 as components of the Shelterin complex is to protect the telomere ends so that genomic integrity is maintained (Celli and de Lange 2005; Denchi and de Lange 2007; Karlseder et al. 1999). Previously the Terf2 gene of the mouse was conditionally targeted only in the liver and skin (Bojovic et al. 2013; Lazzerini Denchi et al. 2006; Martinez et al. 2014). Terf2 inactivation in the basal layer of epidermis using a K14-Cre animal line did not cause embryonic lethality (Bojovic et al. 2013), while Terf2 inactivation in epidermal stem cells using a K5-Cre animal line led to partial embryonic lethality and impaired skin development (Martinez et al. 2014). Similarly, here we demonstrated that a selective inactivation of the Terf2 gene in the neural progenitor cells resulted in embryonic fatality and loss of brain structures, providing another example that the protective role of TERF2 is important to maintain cellular and organismal viability. This result is clearly different from the animal model for selective inactivation of the Terf2 gene in the liver that showed normal liver function and regeneration through endoreduplication without cell division (Lazzerini Denchi et al. 2006). The status of cells, such as proliferating vs. resting cells, most likely contributes to this difference in cellular viability as suggested before (Martinez et al. 2014).

Interestingly, there was no similarity of the neural phenotypes between the Terf2 Nes-Cre and Pot1a Nes-Cre animals (Lee et al. 2014), even though germline deletion of the Terf2 or Pot1a gene in the mouse resulted in embryonic lethality (Celli and de Lange 2005; Hockemeyer et al. 2006; Wu et al. 2006), Pot1a inactivation in neural progenitor cells did not induce massive neural apoptosis during embryogenesis, and the neurological defects resulting from Pot1a inactivation were restricted mainly to the cerebellum (Lee et al. 2014). Furthermore, Pot1a Nes-Cre ;Trp53 / animals did not show any sign of ataxia. On the contrary, Terf2 inactivation in the neural progenitor cells induced more global effects throughout the central nervous system. Also it appeared that there was a differentiation defect of late-born neurons originated from Terf2-null neural progenitor cells which underwent more cell divisions in a Trp53-deficient background.

As illustrated in Fig. 5c, it is possible that the Shelterin complex with all components including POT1 presents only at the end of telomeres where the 3′ single-stranded GC rich overhang is exposed (de Lange 2005; Gramatges and Bertuch 2013; Palm and de Lange 2008). For this reason, the impact resulting from Terf2 inactivation in the neural progenitor cells was more severe than that of Pot1a inactivation in the murine nervous system.

ATM and Trp53 are key signaling mediators in telomere dysfunction due to Terf2 inactivation during brain development in the mouse

One of the interesting observations was the entity of multinucleated giant neural cells only in the Terf2/Trp53 conditional knockout mature brain, possibly resulting from endoreduplication without proper cell division as suggested in other Terf2 conditional knockout animal models (Lazzerini Denchi et al. 2006; Martinez et al. 2014; Ullah et al. 2009). It had been demonstrated that endoreduplication and mitotic failure in a Trp53-dependent manner during telomere crisis lead to polyploid cell accumulation (Davoli and de Lange 2012; Pampalona et al. 2012; Davoli et al. 2010). This defect of multinucleated giant cells was resolved by Lig4 inactivation, suggesting that the ligation function of LIG4 plays a role in this particular neural defect due to telomere dysfunction resulting from Terf2 inactivation during brain development.

Trp53 inactivation suppressed neural apoptosis triggered by Terf2 inactivation in the entire developing nervous system including the VZ in which big metaphase cells could be formed, whereas Atm deficiency could not inhibit programmed cell death in the VZ of the Terf2-null embryonic brain. Therefore, multinucleated giant neural cells were not observed in the Terf2/Atm knockout brain. Also this result suggests that Trp53 activation to induce neural apoptosis in the Terf2-null VZ was Atm-independent. This observation was consistent with the previous reports demonstrating that ATM is involved in neural apoptosis via Trp53 activation in the postmitotic zone, not in the VZ (Lee et al. 2000, 2001; Orii et al. 2006). Apparently, ATR is not the key kinase to activate Trp53 signaling in the Terf2-null VZ, since Atr inactivation did not have any effect on the neural defects in the Terf2-null brain, similar to the in vitro situation (Denchi and de Lange 2007). In addition, there was likely no cross-talk between Atm and Atr signalings responding to telomere dysfunction resulting from Terf2 inactivation during brain development, in contrast to the situation of Pot1a deficiency in the developing brain (Lee et al. 2014). Alternatively, DNA-dependent protein kinase (DNA-PK) might be involved in the Trp53 signaling in the VZ upon DDR induced by Terf2 deficiency (Rybanska-Spaeder et al. 2014).

Taken all together in combination with our previous report (Lee et al. 2014), we demonstrated that TERF2 is more critical to maintain telomere homeostasis than POT1a in the developing mouse brain. Telomere dysfunction by Terf2 inactivation induces the ATM-Trp53 signaling axis to trigger neural apoptosis as a part of the mechanisms to maintain genomic integrity during neurogenesis as illustrated in Fig. 5c. ATM is also activated via ATR signaling by telomere dysfunction due to Pot1a inactivation in the same physiological context.



We are deeply grateful to Dr. Peter McKinnon at St. Jude Children’s Research Hospital, USA for providing experimental materials and vital discussion. We thank the Hartwell Center for biotech support, the cytogenetics core for chromosome analysis and the Animal Resource Center for animal husbandry. We also thank Jingfeng Zhao, Yang Li and Dr. Helen Russell for technical support as well as Stuart Horwitz for English editing. YSL was supported by the NRF of Korea grant funded by the MSIP (Nos. 2011-0030043 and NRF-2014R1A1A2056224). YSL is also supported by the new faculty research fund of Ajou University School of Medicine.

Compliance with ethical standards

Conflict of interest

We declare no conflict of interest regarding this paper.

Ethical approval

All procedures using animal models were approved by the IACUC.

Supplementary material

Supplementary material 1 (MOV 3414 kb)


  1. Bojovic B, Ho HY, Wu J, Crowe DL (2013) Stem cell expansion during carcinogenesis in stem cell-depleted conditional telomeric repeat factor 2 null mutant mice. Oncogene 32(43):5156–5166. doi: 10.1038/onc.2012.555 CrossRefPubMedGoogle Scholar
  2. Celli GB, de Lange T (2005) DNA processing is not required for ATM-mediated telomere damage response after TRF2 deletion. Nat Cell Biol 7(7):712–718. doi: 10.1038/ncb1275 CrossRefPubMedGoogle Scholar
  3. Davoli T, de Lange T (2012) Telomere-driven tetraploidization occurs in human cells undergoing crisis and promotes transformation of mouse cells. Cancer Cell 21(6):765–776. doi: 10.1016/j.ccr.2012.03.044 CrossRefPubMedPubMedCentralGoogle Scholar
  4. Davoli T, Denchi EL, de Lange T (2010) Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell 141(1):81–93. doi: 10.1016/j.cell.2010.01.031 CrossRefPubMedPubMedCentralGoogle Scholar
  5. de Lange T (2005) Shelterin: the protein complex that shapes and safeguards human telomeres. Genes Dev 19(18):2100–2110. doi: 10.1101/gad.1346005 CrossRefPubMedGoogle Scholar
  6. Denchi EL, de Lange T (2007) Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature 448(7157):1068–1071. doi: 10.1038/nature06065 CrossRefPubMedGoogle Scholar
  7. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR (2002) Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci 22(15):6309–6314PubMedGoogle Scholar
  8. Gramatges MM, Bertuch AA (2013) Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy. Transl Res 162(6):353–363. doi: 10.1016/j.trsl.2013.05.003 CrossRefPubMedGoogle Scholar
  9. Graus-Porta D, Blaess S, Senften M, Littlewood-Evans A, Damsky C, Huang Z, Orban P, Klein R, Schittny JC, Muller U (2001) Beta1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex. Neuron 31(3):367–379CrossRefPubMedGoogle Scholar
  10. Greig LC, Woodworth MB, Galazo MJ, Padmanabhan H, Macklis JD (2013) Molecular logic of neocortical projection neuron specification, development and diversity. Nat Rev Neurosci 14(11):755–769. doi: 10.1038/nrn3586 CrossRefGoogle Scholar
  11. Hockemeyer D, Daniels JP, Takai H, de Lange T (2006) Recent expansion of the telomeric complex in rodents: two distinct POT1 proteins protect mouse telomeres. Cell 126(1):63–77. doi: 10.1016/j.cell.2006.04.044 CrossRefPubMedGoogle Scholar
  12. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T (1999) p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 283(5406):1321–1325CrossRefPubMedGoogle Scholar
  13. Lazzerini Denchi E, Celli G, de Lange T (2006) Hepatocytes with extensive telomere deprotection and fusion remain viable and regenerate liver mass through endoreduplication. Genes Dev 20(19):2648–2653. doi: 10.1101/gad.1453606 CrossRefPubMedPubMedCentralGoogle Scholar
  14. Lee Y, Barnes DE, Lindahl T, McKinnon PJ (2000) Defective neurogenesis resulting from DNA ligase IV deficiency requires Atm. Genes Dev 14(20):2576–2580CrossRefPubMedPubMedCentralGoogle Scholar
  15. Lee Y, Chong MJ, McKinnon PJ (2001) Ataxia telangiectasia mutated-dependent apoptosis after genotoxic stress in the developing nervous system is determined by cellular differentiation status. J Neurosci 21(17):6687–6693PubMedGoogle Scholar
  16. Lee Y, Katyal S, Downing SM, Zhao J, Russell HR, McKinnon PJ (2012a) Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors. Nat Neurosci 15(6):819–826. doi: 10.1038/nn.3097 CrossRefPubMedPubMedCentralGoogle Scholar
  17. Lee Y, Shull ER, Frappart PO, Katyal S, Enriquez-Rios V, Zhao J, Russell HR, Brown EJ, McKinnon PJ (2012b) ATR maintains select progenitors during nervous system development. EMBO J 31(5):1177–1189. doi: 10.1038/emboj.2011.493 CrossRefPubMedPubMedCentralGoogle Scholar
  18. Lee Y, Brown EJ, Chang S, McKinnon PJ (2014) Pot1a prevents telomere dysfunction and ATM-dependent neuronal loss. J Neurosci 34(23):7836–7844. doi: 10.1523/JNEUROSCI.4245-13.2014 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Lee Y, Choi I, Kim J, Kim K (2016) DNA damage to human genetic disorders with neurodevelopmental defects. J Genet Med 13(1):1–13. doi: 10.5734/jgm.2016.13.1.1 CrossRefGoogle Scholar
  20. Lovejoy CA, Cortez D (2009) Common mechanisms of PIKK regulation. DNA Repair 8(9):1004–1008. doi: 10.1016/j.dnarep.2009.04.006 CrossRefPubMedPubMedCentralGoogle Scholar
  21. Martinez P, Ferrara-Romeo I, Flores JM, Blasco MA (2014) Essential role for the TRF2 telomere protein in adult skin homeostasis. Aging Cell 13(4):656–668. doi: 10.1111/acel.12221 CrossRefPubMedPubMedCentralGoogle Scholar
  22. McKinnon PJ (2012) ATM and the molecular pathogenesis of ataxia telangiectasia. Ann Rev Pathol 7:303–321. doi: 10.1146/annurev-pathol-011811-132509 CrossRefGoogle Scholar
  23. McKinnon PJ (2013) Maintaining genome stability in the nervous system. Nat Neurosci 16(11):1523–1529. doi: 10.1038/nn.3537 CrossRefPubMedPubMedCentralGoogle Scholar
  24. Nam EA, Cortez D (2011) ATR signalling: more than meeting at the fork. Biochem J 436(3):527–536. doi: 10.1042/BJ20102162 CrossRefPubMedPubMedCentralGoogle Scholar
  25. Orii KE, Lee Y, Kondo N, McKinnon PJ (2006) Selective utilization of nonhomologous end-joining and homologous recombination DNA repair pathways during nervous system development. Proc Natl Acad Sci USA 103(26):10017–10022. doi: 10.1073/pnas.0602436103 CrossRefPubMedPubMedCentralGoogle Scholar
  26. Palm W, de Lange T (2008) How shelterin protects mammalian telomeres. Annu Rev Genet 42:301–334. doi: 10.1146/annurev.genet.41.110306.130350 CrossRefPubMedGoogle Scholar
  27. Pampalona J, Frias C, Genesca A, Tusell L (2012) Progressive telomere dysfunction causes cytokinesis failure and leads to the accumulation of polyploid cells. PLoS Genet 8(4):e1002679. doi: 10.1371/journal.pgen.1002679 CrossRefPubMedPubMedCentralGoogle Scholar
  28. Rybanska-Spaeder I, Ghosh R, Franco S (2014) 53BP1 mediates the fusion of mammalian telomeres rendered dysfunctional by DNA-PKcs loss or inhibition. PLoS One 9(9):e108731. doi: 10.1371/journal.pone.0108731 CrossRefPubMedPubMedCentralGoogle Scholar
  29. Sfeir A, de Lange T (2012) Removal of shelterin reveals the telomere end-protection problem. Science 336(6081):593–597. doi: 10.1126/science.1218498 CrossRefPubMedPubMedCentralGoogle Scholar
  30. Shull ER, Lee Y, Nakane H, Stracker TH, Zhao J, Russell HR, Petrini JH, McKinnon PJ (2009) Differential DNA damage signaling accounts for distinct neural apoptotic responses in ATLD and NBS. Genes Dev 23(2):171–180. doi: 10.1101/gad.1746609 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Smogorzewska A, Karlseder J, Holtgreve-Grez H, Jauch A, de Lange T (2002) DNA ligase IV-dependent NHEJ of deprotected mammalian telomeres in G1 and G2. Curr Biol CB 12(19):1635–1644CrossRefPubMedGoogle Scholar
  32. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein R, Schutz G (1999) Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety. Nat Genet 23(1):99–103. doi: 10.1038/12703 CrossRefPubMedGoogle Scholar
  33. Ullah Z, Lee CY, Lilly MA, DePamphilis ML (2009) Developmentally programmed endoreduplication in animals. Cell Cycle 8(10):1501–1509. doi: 10.4161/cc.8.10.8325 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Wu L, Multani AS, He H, Cosme-Blanco W, Deng Y, Deng JM, Bachilo O, Pathak S, Tahara H, Bailey SM, Deng Y, Behringer RR, Chang S (2006) Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres. Cell 126(1):49–62. doi: 10.1016/j.cell.2006.05.037 CrossRefPubMedGoogle Scholar
  35. Zhang P, Furukawa K, Opresko PL, Xu X, Bohr VA, Mattson MP (2006) TRF2 dysfunction elicits DNA damage responses associated with senescence in proliferating neural cells and differentiation of neurons. J Neurochem 97(2):567–581. doi: 10.1111/j.1471-4159.2006.03779.x CrossRefPubMedGoogle Scholar
  36. Zhang P, Dilley C, Mattson MP (2007) DNA damage responses in neural cells: focus on the telomere. Neuroscience 145(4):1439–1448. doi: 10.1016/j.neuroscience.2006.11.052 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2017

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Authors and Affiliations

  1. 1.Genomic Instability Research Center, School of MedicineAjou UniversitySuwonRepublic of Korea
  2. 2.Department of Biomedical Sciences, The Graduate SchoolAjou UniversitySuwonRepublic of Korea

Personalised recommendations